Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

386
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
386
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Consumer Engagement in Chronic Conditions Research: An Integrated Framework Informed by Recognition Theory.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Measuring Fatigue in Multiple Sclerosis: A Rapid Review.

The patient·2025
Same author

Disentangling Blood-Based Markers of Multiple Sclerosis Through Machine Learning: An Evaluation Study.

Studies in health technology and informatics·2025
Same author

Co-Designing a Multiple Sclerosis Fatigue App.

Studies in health technology and informatics·2025
Same author

Supporting consumer engagement in health research about chronic conditions: a scoping review of evidence-based resources.

Research involvement and engagement·2025
Same author

Metal Oxide-Metal Organic Framework Layers for Discrimination of Multiple Gases Employing Machine Learning Algorithms.

ACS applied materials & interfaces·2025

相关实验视频

Updated: Sep 12, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.8K

在1型糖尿病中对葡萄糖调节进行决定性和随机强化学习的比较

David Timms1, Chirath Hettiarachchi1, Hanna Suominen1,2

  • 1The Australian National University, Australia.

Studies in health technology and informatics
|August 8, 2025
PubMed
概括

强化学习 (RL) 算法在1型糖尿病 (T1D) 管理中显示出对自主人工胰腺系统 (APS) 的承诺. 像PPO这样的随机算法通常优于确定性TD3,尽管可解释性仍然是两者的挑战.

科学领域:

  • 生物医学工程 生物医学工程
  • 人工智能在医学中的应用
  • 内分泌学 在内分泌学.

背景情况:

  • 1型糖尿病 (T1D) 需要持续的血糖监测和胰岛素治疗.
  • 目前的人工胰腺系统 (APS) 需要手动输入,造成认知负担.
  • 强化学习 (RL) 提供了在APS中自主调节葡萄糖的潜在解决方案.

研究的目的:

  • 为了比较静态 (PPO) 和确定性 (TD3) RL算法的在中葡萄糖调节的有效性.
  • 用定量,定性和患者特定的指标来评估RL算法性能.
  • 评估不同RL方法对APS的安全性和适用性.

主要方法:

  • 在使用UVA/PADOVA 2008 T1D模拟器进行in silico评估.
  • 接近政策优化 (PPO) 和双延迟深确定性政策梯度 (TD3) 算法的比较.
  • 使用了定量指标,定性评估和患者特定的临床数据.

主要成果:

  • 无论是PPO还是TD3,都显示出自主调节葡萄糖的潜力.
  • 在模拟中,PPO与TD3相比,在模拟中总体上表现出更高的性能.
  • TD3表现出更容易解释的行为,但这并不总是与更好的结果相关.
关键词:
人工胰腺是一种人工胰腺.深度学习 (Deep Learning) 是一种深度学习.评估研究 评估研究一类糖尿病 一类糖尿病

更多相关视频

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

6.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

相关实验视频

Last Updated: Sep 12, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.8K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

6.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

结论:

  • RL算法有望通过APS减少T1D管理的负担.
  • 需要进一步的研究,以提高RL算法的可解释性和预测性能在APS.
  • 选择算法需要仔细考虑性能和安全性/可解释性.